Arena Cuts Jobs In R&D Overhaul | Chemical & Engineering News
Volume 93 Issue 43 | p. 23 | Concentrates
Issue Date: November 2, 2015

Arena Cuts Jobs In R&D Overhaul

Department: Business
Keywords: pharmaceuticals, biotech, jobs, obesity

Arena Pharmaceuticals is cutting 35% of its U.S. workforce—or roughly 80 jobs—as it narrows its R&D focus to drug candidates that already have reached the clinic. The layoffs are expected to save the San Diego-based biotech $11 million annually. Arena plans further job cuts at its Swiss manufacturing facility. It also will jettison certain programs related to its obesity drug lorcaserin, including testing the pill in combination with phentermine as a smoking cessation treatment. The biotech determined that FDA’s request for larger clinical trials was financially unsustainable.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment